AI-generated from publicly available materials.PeriGen is leveraging AI technology to enhance fetal monitoring during labor and delivery, aiming to improve outcomes for mothers and infants.
The company has developed FDA-cleared algorithms that utilize AI to analyze fetal monitoring strips with remarkable precision, interpreting data every millisecond. This advancement addresses the traditionally subjective nature of fetal monitoring, as noted by PeriGen’s CEO, Matthew Sappern. He emphasizes the importance of electronic fetal monitoring as the standard for assessing the health of both mother and baby during labor.
One of the critical benefits of this technology is its potential to prevent adverse events, including serious complications arising from oxygen deprivation during birth. Sappern highlights that timely and accurate interventions can significantly reduce the likelihood of malpractice lawsuits, as obstetrics is known for its high liability rates. Notably, the implementation of this AI-driven solution has led to impressive outcomes in various hospitals, including an 82% reduction in neonatal deaths in Malawi and a significant decrease in stillbirths at Baylor College of Medicine.
This innovative approach not only enhances clinical safety but also demonstrates the growing impact of AI in healthcare, particularly in improving maternal and neonatal health outcomes. As PeriGen continues to expand its market presence, collaborations with organizations like the Gates Foundation indicate a commitment to addressing healthcare challenges in diverse settings, such as Nairobi, Kenya.